title: Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Weigl
authors.forename: Nili
authors.initials: N
authors.lastname: Arbel
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D002547:Cerebral Palsy / Q000188:drug therapy*; D002675:Child, Preschool; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D028761:Withholding Treatment
chemical_list: D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A